Even for a puppy, Kat Donatello’s black lab, Austin, was hyperactive. After experimenting with natural supplements on her older dog, Brady, Donatello slipped the puppy a special biscuit.
“It just kind of took the edge off of him,” she said.
The treat contained cannabidiol, better known as CBD, a chemical compound extracted from the marijuana plant.
Photo: AP
The CBD supplements were expensive, and options for pet treats were limited, Donatello said.
“So I started spending my winters baking dog biscuits,” she said, adding that she tinkered with the recipe before launching her CBD-laced biscuit company, Austin + Kat, earlier this year.
Along with Therabis and Treatibles, Austin + Kat is one of several cannabidiol-for-dogs businesses that have popped up in the past two years, a time period during which CBD pet product sales doubled in the US, according to data kept by cannabis industry analytics firm MJ Freeway.
It is the newest trend in the US’ booming half-billion dollar animal supplements market, which is expected to grow by more than US$150 million in the next four years.
CBD is one of over 80 active cannabinoid chemicals in marijuana, according to the National Institute on Drug Abuse.
Unlike tetrahydrocannabinol (THC), CBD does not create a euphoric sensation. In other words, these biscuits will not get your dog high, but there is some debate as to what effect the compound has on our furry friends and whether they should be consuming it at all.
Academic research about CBD’s affect on animals is nearly nonexistent, and the US Food and Drug Administration has not approved marijuana use in animals. Despite this, some veterinarians recommend their use, and producers say pet stores are increasingly beginning to carry CBD treats. Treatibles is even in talks to be sold at a big box pet store, though an executive would not reveal which one, as the deal is still pending.
Veterinarians’ views on the supplement vary. When asked about the effectiveness of CBD in dogs, veterinarian Robert Goggs said there is “virtually no evidence in the veterinary literature on this.”
By contrast, veterinarians Robert Silver and Gary Richter recently hosted a course on the cannabis-dedicated learning Web site Green Flower entitled the “Cannabis for Pets Masterclass.”
Contacted by phone, Richter conceded that scholarly literature is lacking.
“A lot of what we’re using is extrapolated data from humans, as well as just real world experience on what works,” he explained.
If it works for humans, he said, it could work for dogs.
In lieu of research, the CBD-for-dogs industry cites supportive veterinarians and customer testimonials as evidence of the products’ effectiveness.
On Treatibles’ Web site, an interview with the owner of mixed-breed pup Shelby shows how the dog, plagued with anxiety and fear, was able to settle down after eating a laced treat.
Human studies have linked CBD to anti-seizure, anti-inflammatory and anti-anxiety effects. In findings presented to the US Senate on International Narcotics Control in June last year, National Institute on Drug Abuse director Nora Volkow said CBD could potentially aid those suffering from Alzheimer’s, stroke, multiple sclerosis and Parkinson’s.
Despite the largely positive feedback in Volkow’s presentation, she warned that additional research on CBD is necessary.
The Drug Enforcement Administration (DEA) agrees and hopes to review further scientific studies on CBD.
CBD is often purchased online, which is technically a violation of US federal law, according to DEA spokesman Russell Baer.
“Extracts or derivatives from the cannabis plant are Schedule I controlled substances — just like the plant itself,” Baer said in an e-mailed statement. “There is widespread illegal distribution of purported CBD products — regardless if they are derived from the marijuana plant or hemp plant,” he added.
Understandably, the DEA’s attention is not on CBD at a time when the US faces an opioid crisis, and sterilized cannabis seeds can be legally used in animal feed mixture.
When asked about the legality of the business, Therabis called it a “complex situation.”
Austin + Kat’s Donatello expressed frustration with the DEA’s position in light of the US Controlled Substances Act and her ability to purchase CBD products at Walmart.com.
Treatibles did not reply to a request for comment.
There is also the matter of ethics.
Humans can verbally express discomfort when trying a new treatment. Dogs cannot.
“If the proper administration of marijuana can truly relieve dogs’ pain, then they should be given the same consideration that humans in pain are given, with regular doses to help reduce their misery,” People for the Ethical Treatment of Animals senior vice president Daphna Nachminovitch said. “But it’s an entirely different matter to amuse oneself by getting the cat drunk or the dog high.”
While the researchers debate what, exactly, CBD can do for Fido, investors are excited by its increasing popularity, which has been buoyed by the US legalization of cannabis (for humans) and increased dialogue about the medicinal properties of marijuana.
Treatibles founder Julianna Carella has seen sales explode “like wildfire” over the past two years.
Therabis has experienced equally explosive growth in its first year of business; since February, the company has seen revenue quadruple, and sales have grown 30 percent month-on-month, according to Joe Hodas, chief marketing officer of the treat brand’s parent company.
Troy Dayton, cofounder of the Arcview Group, an Oakland, California-based investment firm, was a skeptic before he saw the sales numbers.
“If humans are noticing in droves all the different ways where cannabis products can have utility for them, then surely there will be a massive application [for animals],” he said.
Over the past two years, Arcview has been involved in fundraising efforts for two CBD pet-product companies.
Dayton anticipates that additional capital will follow, particularly from investors leery of getting into the recreational cannabis market, which is legally murky.
“There’s a lot of opportunity” in the CBD market, Dayton said.
“I’m not surprised at all that the space is growing,” Carella said. “There’s so many pet owners that would do just about anything to relieve their animals’ suffering.”
POWERING UP: PSUs for AI servers made up about 50% of Delta’s total server PSU revenue during the first three quarters of last year, the company said Power supply and electronic components maker Delta Electronics Inc (台達電) reported record-high revenue of NT$161.61 billion (US$5.11 billion) for last quarter and said it remains positive about this quarter. Last quarter’s figure was up 7.6 percent from the previous quarter and 41.51 percent higher than a year earlier, and largely in line with Yuanta Securities Investment Consulting Co’s (元大投顧) forecast of NT$160 billion. Delta’s annual revenue last year rose 31.76 percent year-on-year to NT$554.89 billion, also a record high for the company. Its strong performance reflected continued demand for high-performance power solutions and advanced liquid-cooling products used in artificial intelligence (AI) data centers,
SIZE MATTERS: TSMC started phasing out 8-inch wafer production last year, while Samsung is more aggressively retiring 8-inch capacity, TrendForce said Chipmakers are expected to raise prices of 8-inch wafers by up to 20 percent this year on concern over supply constraints as major contract chipmakers Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) and Samsung Electronics Co gradually retire less advanced wafer capacity, TrendForce Corp (集邦科技) said yesterday. It is the first significant across-the-board price hike since a global semiconductor correction in 2023, the Taipei-based market researcher said in a report. Global 8-inch wafer capacity slid 0.3 percent year-on-year last year, although 8-inch wafer prices still hovered at relatively stable levels throughout the year, TrendForce said. The downward trend is expected to continue this year,
Vincent Wei led fellow Singaporean farmers around an empty Malaysian plot, laying out plans for a greenhouse and rows of leafy vegetables. What he pitched was not just space for crops, but a lifeline for growers struggling to make ends meet in a city-state with high prices and little vacant land. The future agriculture hub is part of a joint special economic zone launched last year by the two neighbors, expected to cost US$123 million and produce 10,000 tonnes of fresh produce annually. It is attracting Singaporean farmers with promises of cheaper land, labor and energy just over the border.
A proposed billionaires’ tax in California has ignited a political uproar in Silicon Valley, with tech titans threatening to leave the state while California Governor Gavin Newsom of the Democratic Party maneuvers to defeat a levy that he fears would lead to an exodus of wealth. A technology mecca, California has more billionaires than any other US state — a few hundred, by some estimates. About half its personal income tax revenue, a financial backbone in the nearly US$350 billion budget, comes from the top 1 percent of earners. A large healthcare union is attempting to place a proposal before